Ametros said it expanded its drug monitoring program to track the use of controlled substances on Medicare Set-Asides it administers, following new guidance from the Centers for Medicare and Medicaid Services.
CMS recently updated Version 3.0 of its Workers’ Compensation Medicare Set-Aside Arrangement Reference Guide to “highly recommend” professional administration in cases where a claimant is taking opioids, benzodiazepines and other “frequently abused drugs.”
Ametros said it expanded its drug monitoring program protocol, incorporating new recommendations so the program now:
Ametros provides pharmacy discounts and clinical management services as part of its CareGuard program for its members, who are patients with medical settlements resulting from personal injuries.
Jun 2, 2020
Overview: With a clinical background in mindfulness, stress management, grief recovery, and critic …
Jun 11, 2020
Join our webinar presented by Employers' Fraud Task Force on Thursday, June 11th, and hear from a …
Jun 20, 2020
Overview: Our panel discussion offers an extensive look into the legal aspects from three differe …